Why GeneLit?

GeneLit.com last updated:
Nov 12, 2018 @ 12:42 pm.

Introducing a new online / mobile / email service designed specifically for genetic counselors and other genetics professionals. To save you time. To increase your knowledge of the current medical genetics literature and your comfort in staying ahead of the ever-mounting flood of newly released papers. To make your clinical life easier, but also make you more responsive to your patient's / client's needs and care.

Just Show Me!

The Current LitLists:

  • Genetics of Breast & Ovarian Cancer
  • How Much Does It Cost?

    All content and features of GeneLit.com are open to all, but it requires your support to survive and grow. If you use GeneLit.com, find value in it, and want it to expand to meet your further needs, pay for it what you think it is worth to you. We call it "Pay-What-You-Want/Value". How does that work?

    Please Subscribe Now

    Current Features of GeneLit.com

    • Access to comprehensive coverage of the medical literature, and some popular media, of Hereditary/Familial/Genetic Breast and Ovarian Cancer, currently going back at least five years, and being expanded to cover the entire history.

    • Organized for quick reference into nearly 20 clinically-relevant categories, each of these broken down into between 3-6 to more than a dozen subcategories (known as "LitLists").

    • Categories were determined organically, dictated by the literature itself, with consideration to clinical use by genetics professionals themselves.
    • LitLists are sorted in reverse chronology, so that the most recently available papers sit at the top.
    • New LitLists are "split" off as the literature evolves and grows in different areas, to optimize finding the information you need quickly.

    • Links to newly published and "early released" references are posted within a few days of becoming available online, sometimes before wide release via PubMed. Don't even want to spend the time to visit the LitLists? Check out our email notification service -- LitAlerts.

    • LitLists include sources beyond the scope of PubMed, including popular press/media, videos/webinars, blog posts, etc.--anything that may be of interest to genetic counselors and other genetics professionals (and, by extension, to their patients/clients), and other health care providers wishing to expand their genetics knowledge.

    • If you prefer that the medical literature comes to you, sign up to receive LitAlerts in your email as soon as references are posted to GeneLit, for any categories of your choice or to all of "Genetics of Breast & Ovarian Cancer" itself.

    Please note* that GeneLit provides citation information only and links to the referenced papers, but not full-text access to the every paper itself. When a paper's full text is freely and publicly available, GeneLit usually provides a direct link, but cannot provide free access to those papers that require a subscription with the third-party publisher.

    The Future of GeneLit

    Expansion is proceeding to include topics of interest and clinical importance to genetics professionals, and to include additional genetic syndromes and conditions, even beyond the field of cancer genetics.

    We hope to add on-site tools and features to help you further manage references for your clinical use.

    Statement of Purpose

    Identification of Standard of Practice and documentation of the medical literature supporting a plan of action or course of testing or treatment are important to any medical practice, especially so in the rapidly advancing field of medical/clinical genetics. Finding key studies among the ever-mounting flood of published medical research is a constant challenge. Staying informed of the most recent findings relevant to your patients' care is even more so.

    Electronic databases and search algorithms are available in this arena, but often leave you awash among thousands or tens of thousands of "hits", even when you spend your time trying to craft exacting search terms. Upon closer examination, many of these hits are of dubious relevance—requiring time-consuming "weeding" to get what you need. Spend more time making the search terms more specific; now you wonder what important references might be excluded. Who has time for all this in the day-to-day clinical crush? (GeneLit.com does, but why should it be expected of every single genetic counselor and other genetics professional, querying the same or similar clinical questions?)

    GeneLit.com provides categories of topics, targeted to the real questions most relevant to genetics professionals in the clinic. Addressing these topics/questions are "LitLists" of supporting references gleaned from throughout the online universe, each abstract hand-picked, individually vetted, and human-curated, not just spat out by a search engine or a computer algorithm.

    You can gain access to these valuable curated references in several ways: (1) by browsing the archival LitLists—which begin with the just-published (and even early-released, at times ahead of PubMed indexing) and span back through the original research from historical medical journal volumes; and (2) by receiving links to the very latest papers or pre-prints—on any GeneLit.com topics of your choosing—just as they are released, directly to your e-mail inbox.

    GeneLit.com begins its existence in development, and always will be in constant development, growing and responding in kind with the medical genetics literature itself. Premiering with the vast literature on hereditary/familial Breast and Ovarian Cancer, GeneLit.com will progressively add conditions and topics important to the practices of most genetics professionals. New online features and tools to manage the medical genetics literature are also being developed and will be added with time.

    Please note* that GeneLit.com provides you with reference information and links to such material but it is not a service to provide files of, or free access to, the full text versions of all of these references. Users must provide their own access to, or provide separate payment for, such full-text access when material is protected by copyright by the third-party, original content publishers.